Skip to content

Mindfulness Processes and User Experiences in a Randomized Controlled Trial of the Mindfulness Coach App for Veterans with Posttraumatic Stress Disorder

Shilpa Hampole, Haijing Wu Hallenbeck, Joseph Wielgosz, Kelly M Ramsey, Jason E. Owen, Robyn D. Walser

Mindfulness July 11, 2026 DOI: 10.1007/s12671-026-02930-7 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Qualitative Peer reviewed
Sample size 173
Population U.S. veterans with PTSD
Duration 8-week intervention, 1-year follow-up
Topics Meditation PTSD
Keywords Randomized controlled trial Psychological intervention Context archaeology Coping psychology Posttraumatic stress Mental health Clinical psychology Psychotherapist Flexibility engineering Attrition Repeated measures design Qualitative research
Registration NCT04035304
Key findings The Mindfulness Coach app produced significant between-group improvements in two mindfulness facets (describing and nonjudgment) among study completers, and qualitative data suggested perceived mental health benefits.

Abstract

Abstract Objectives Mindfulness-based digital interventions have shown promise for improving health outcomes. The Mindfulness Coach (MC) mobile app was found to improve posttraumatic stress disorder (PTSD) and depression symptoms in a pilot randomized controlled trial (RCT). The current secondary analyses expand on these findings by assessing changes in mindfulness-related processes targeted by the app and by qualitatively exploring users’ experiences to better understand how Mindfulness Coach may support these processes in the context of PTSD.

Method: U.S. veterans with PTSD ( n = 173) were randomized to an 8-week MC ( n = 86) or waitlist control (WL; n = 87) condition. After study attrition due to technical issues and participant dropout, 56 participants (MC: n = 19; WL: n = 37) completed follow-up surveys. A secondary quantitative intent-to-treat analysis was conducted on process outcomes related to facets of mindfulness, psychological flexibility, interoceptive awareness, and thought suppression using linear mixed modeling with maximum likelihood estimation for missing values. A Rapid Qualitative Analysis of 1-year follow-up interviews with a subsample of participants in the MC condition ( n = 21) examined PTSD-related coping responses, knowledge and experiences related to mindfulness practice prior to the study, as well as use and perceptions of Mindfulness Coach and its potential impact.

Results: Among study completers (MC: n = 19; WL: n = 37), there were significant between-group effects for two facets of mindfulness (i.e., describing and nonjudgment; p -values < 0.05). Significant within-group effects for both conditions were also found for psychological flexibility ( p -values < 0.05). Qualitative results revealed mostly positive user experiences, potential barriers to use, and perceived improvements in stress, PTSD symptoms, and sleep.

Conclusions: This study showed improvements in mindfulness processes targeted by Mindfulness Coach and perceived mental health benefits with app use, supporting its value as an on-demand resource for veterans with PTSD. High attrition rates limit the strength and generalizability of these findings and underscore the challenges of sustaining engagement with self-guided digital interventions. However, this low-cost and scalable tool holds promise as an option for veterans with PTSD that can extend the reach of evidence-based mindfulness strategies to improve mental health care. Preregistration ClinicalTrials.gov, TRN: NCT04035304, Registration date: 24 July 2019.

Comparable studies

Other randomized controlled trials on PTSD, most cited first.

Study Year Design Participants
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Patients with severe PTSD, including those with comorbidities such as dissociation,... 2021 Randomized controlled trial n = 90
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Patients with treatment-resistant PTSD 2012 Randomized controlled trial n = 12

Citations in the library

Explore topics